Topics Covered in Taiwan Ophthalmology Drugs and Devices Market Report
Taiwan Ophthalmology Drugs and Devices Market Report thoroughly covers the market by products, indication and end use. Taiwan Ophthalmology Drugs and Devices Market Outlook report provides an unbiased and detailed analysis of the ongoing Taiwan Ophthalmology Drugs and Devices Market trends, opportunities/high growth areas, and market drivers. This would help stakeholders devise and align their market strategies according to the current and future market dynamics.
Taiwan Ophthalmology Drugs and Devices Market Synopsis
Taiwan’s healthcare system is globally recognized as one of the best. According to the 2023 Health Care Index by CEOWORLD and the 2024 Health Care Index by NUMBEO, Taiwan ranked first globally, highlighting the strength and resilience of its healthcare infrastructure. Consequently, the ophthalmology drugs and devices market in Taiwan is well-positioned for growth in the near future. This expansion is anticipated to be driven by advancements in healthcare infrastructure, government initiatives, and the country’s aging population. As of 2023, Taiwan had 406 hospitals, 23,420 clinics, and 286,823 healthcare professionals, underscoring the extensive resources supporting its healthcare sector.
According to 6Wresearch, Taiwan Ophthalmology Drugs and Devices Market revenues is projected to grow at a CAGR of 8.1% respectively during 2025-2031F. The growth of Taiwan's ophthalmology market is primarily driven by the National Health Insurance (NHI) program and the increasing influx of medical tourism. Patients from the United States and Europe are drawn to Taiwan for more affordable medical care, for instance, a cataract surgery costing approximately $9,700 in the U.S. is available in Taiwan for around $1,000. Additionally, the number of NHI beneficiaries aged 65 and above increased by 192,000 in 2023 compared to 2022. Taiwan's demographic trends further highlight the growing need for ophthalmic care.
The share of the population under 15 years of age has declined from 45% in 1960 to just 12% in 2022, while by 2025, the country is projected to transition into a “super-aged society,” with 20% of its population aged 65 or older, indicating a rapidly aging population that is increasingly susceptible to eye-related conditions such as cataract, glaucoma and others. Additionally, the government’s investment in smart healthcare is accelerating the development of smart hospitals in Taiwan. Institutions such as National Taiwan University Hospital, Taichung Veterans General Hospital, and Changhua Christian Hospital are expected to adopt advanced technologies and solutions, further driving the growth of the ophthalmology market.
Market Segmentation By Products
Diagnostic and monitoring devices are anticipated to witness significant growth in the coming years, driven by the rising prevalence of eye-related conditions. The increasing incidence of conditions such as glaucoma, cataracts, diabetic retinopathy, and macular degeneration necessitates the use of specialized and advanced diagnostic tools.
Market Segmentation By Indication
The retinal disorders segment is projected to experience significant growth, primarily driven by the rising prevalence of conditions such as diabetic retinopathy, macular degeneration, and retinal vein occlusion, particularly among the aging population.
Market Segmentation By End Use
Hospitals are expected to experience faster growth compared to clinics, driven by the emergence of smart healthcare facilities. Institutions such as Taichung Veterans General Hospital and Changhua Christian Hospital are at the forefront of this expansion, contributing significantly to the sector's growth trajectory.
Key Attractiveness of the Report
- 10 Years Market Numbers.
- Historical Data Starting from 2021 to 2024.
- Base Year: 2024
- Forecast Data until 2031
- Key Performance Indicators Impacting the Market.
- Major Upcoming Developments and Projects.
Key Highlights of the Report
- Taiwan Ophthalmology Drugs and Devices Market Overview
- Taiwan Ophthalmology Drugs and Devices Market Outlook
- Taiwan Ophthalmology Drugs and Devices Market Forecast
- Industry Life Cycle
- Porter’s Five Forces Analysis
- Historical Data and Forecast of Taiwan Ophthalmology Drugs and Devices Market Revenues for the Period 2021-2031F
- Historical Data and Forecast of Taiwan Ophthalmology Drugs and Devices Market Revenues, By Products, for the Period 2021-2031F
- Historical Data and Forecast of Taiwan Ophthalmology Drugs and Devices Market Revenues, By Indication, for the Period 2021-2031F
- Historical Data and Forecast of Taiwan Ophthalmology Drugs and Devices Market Revenues, By End Use, for the Period 2021-2031F
- Market Drivers and Restraints
- Market Evolution & Trends
- Market Opportunity Assessment
- Competitive Benchmarking
- Company Profiles
- Key Strategic Recommendations
Market Scope and Segmentation
The report provides a detailed analysis of the following market segments:
By Products
- Diagnostic and Monitoring Devices
- Surgical Devices
- Vision Care
- Drugs
By Indication
- Cataract
- Retinal Disorders
- Dry Eye
- Glaucoma
- Others (Allergy, Infection, etc)
By End Use
- Hospitals
- Clinics
